Salarius Pharmaceuticals Inc

NASDAQ:SLRX  
0.72
-0.05 (-6.85%)
5:41:52 PM EDT: $0.77 +0.05 (+6.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Salarius Pharmaceuticals Inc Stock, NASDAQ:SLRX

2450 Holcombe Boulevard, Suite X, Houston, Texas 77021
United States of America
Phone: +1.832.834.6992
Number of Employees: 12
http://salariuspharma.com

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.